Harbin Medisan Pharmaceutical (002900.SZ): Potassium chloride sodium chloride solution passes generic drug consistency evaluation.

Harbin Medisan Pharmaceutical (002900.SZ) announced that the company recently received a drug supplementary application approval notice issued by the State Food and Drug Administration. The company's drug potassium chloride sodium chloride injection has passed the evaluation of generic drug quality and efficacy consistency.